On August 19, China Cord Blood Corporation (NYSE:CO), China’s top umbilical cord blood storage services provider, released its preliminary unaudited financial results for …
Cytori Therapeutics (NASDAQ:CYTX) announced that BARDA executed the option to fund the continued development of Cytori Cell Therapy for thermal burn injuries. The current …
In a report issued yesterday, Roth Capital analyst Dave King affirmed coverage on Black Diamond (BDE) with a Buy rating and reduced his price target to $10 (from $11). …
Roth Capital’s analyst Philip Shen today maintained a Buy rating on Hudson Technologies Inc. (HDSN) and sets the target price at $6.
In a research note released today, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on Ligand Pharmaceutical (LGND) and a price target of $92.00 following …